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One-sentence summary: The ion channel TPC2 is required for Ca2+ mobilization from lysosomes in response 
to mTORC1 inhibition and to NAADP. 
 
Editor’s summary: 
Channeling lysosomal Ca2+ 
Autophagy, or the digestion of macromolecules and organelles by lysosomes, is regulated by the 
multiprotein complex mTORC1. TPC2 is a lysosomal channel that carries Ca2+ or Na+  flux in response to 
different ligands and promotes the termination of autophagy. Using mouse pulmonary arterial myocytes and 
cells expressing TPC2, Ogunbayo et al. identified mTORC1 inhibition as a mechanism for TPC2 activation 
that led to the mobilization of Ca2+ from lysosomes. Furthermore, they showed that TPC2 may be regulated 
by mTORC1 inhibition and NAADP through a common pathway. Autophagy is increased in pulmonary 
hypertension, and the authors suggest that modulating TPC2 activity could be a promising therapeutic 
strategy for this condition, which currently lacks effective treatments. 
 
mTORC1 controls lysosomal Ca2+ release through the two-pore channel TPC2  
 
 
1Oluseye A. Ogunbayo, 1Jingxian Duan, 2Jian Xiong, 2Qiaochu Wang, 2Xinghua Feng, 3Jianjie Ma, 
2Michael X. Zhu, 1A. Mark Evans 
 
1Centres for Discovery Brain Sciences and Cardiovascular Sciences, Edinburgh Medical School: Biomedical 
Sciences, University of Edinburgh, Edinburgh, EH8 9XD, Scotland UK.   
2Department of Integrative Biology and Pharmacology, McGovern Medical School, Program in 
Biochemistry and Cell Biology, Graduate School of Biomedical Sciences, The University of Texas Health 
Science Center at Houston, Houston, TX 77030, USA.  
3Department of Surgery, Davis Heart and Lung Research Institute, The Ohio State University, Columbus, 
OH 43210, USA. 
 
Corresponding Author: A. Mark Evans, 1Centres for Discovery Brain Sciences and Cardiovascular Sciences, 
Edinburgh Medical School: Biomedical Sciences, University of Edinburgh, Hugh Robson Building, George 
Square, Edinburgh EH8 9XD, UK 
Fax: +44 (0) 131 650 6527; Telephone: +44 (0) 131 651 1501; Email: mark.evans@ed.ac.uk 
 
Abstract 
Two-pore segment channel 2 (TPC2) is a ubiquitously expressed, lysosomally targeted ion channel that aids 
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in terminating autophagy and is inhibited upon its association with mechanistic target of rapamycin (mTOR). 
It is controversial whether TPC2 mediates lysosomal Ca2+ release or selectively conducts Na+, and whether 
the binding of nicotinic acid adenine dinucleotide phosphate (NAADP) or phosphatidylinositol 3,5-
bisphosphate (PI(3,5)P2) is required for the activity of this ion channel. Here we show that TPC2 is required 
for intracellular Ca2+ signaling in response to NAADP or to mTOR inhibition by rapamycin. In pulmonary 
arterial myocytes, rapamycin and NAADP evoked global Ca2+ transients that were blocked by depletion of 
lysosomal Ca2+ stores. Pre-incubation of cells with high concentrations of rapamycin resulted in 
desensitization and blocked NAADP-evoked Ca2+ signals. Moreover, rapamycin and NAADP did not evoke 
discernable Ca2+ transients in myocytes derived from Tpcn2 knockout mice, which showed normal responses 
to other Ca2+-mobilizing signals. In HEK293 cells stably overexpressing human TPC2, shRNA-mediated 
knockdown of mTOR blocked rapamycin- and NAADP-evoked Ca2+ signals. Confocal imaging of a 
genetically encoded Ca2+ indicator fused to TPC2 demonstrated that rapamycin-evoked Ca2+ signals 
localized to lysosomes and were in close proximity to TPC2. Therefore, inactivation of mTOR may activate 
TPC2 and consequently lysosomal Ca2+ release. 
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INTRODUCTION  
The two-pore segment channels (TPCs) (1) are NAADP-gated Ca2+ release channels that are targeted to 
endolysosomes (2-7). Consistent with this view TPC1, TPC2 and TPC3, of which only TPCN1 and TPCN2 
genes (2, 8) are present in humans, rats and mice, are homologous with and represent an evolutionary 
intermediate between some Ca2+-permeable transient receptor potential (TRP) channels and voltage-gated 
Ca2+ channels (CaV), with an intermediate two-domain structure of subunits which likely assemble as 
homodimers (2, 8). However, controversy surrounds the capacity of TPC2 to support an NAADP-gated Ca2+ 
conductance, given that others have demonstrated that human TPC2 expressed in several different 
mammalian cell types is highly selective for Na+ and carries a Na+ conductance in response to 
phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) but not NAADP (7, 9, 10). Countering this notion, cells 
derived from Tpcn1 and Tpcn2 null mice generate PI(3,5)P2-mediated cation currents but not NAADP-gated 
Ca2+ currents, and NAADP-dependent cation currents are restored in Tpcn1 and Tpcn2 null cells by 
overexpression of wild type TPC2 (11). That said, it is clear that TPC2 mediates a Na+ conductance that is 
gated by inhibition of mechanistic Target of Rapamycin (mTOR) (10) and TPC2 contributes to autophagy 
termination and mTOR reactivation (12). Activation of mTORC1 has been implicated in the progression of 
diseases such as pulmonary hypertension for which current therapies are ineffective (13). Therefore, we 
sought to determine whether TPC2 mediates lysosomal Ca2+ signals in pulmonary arterial myocytes upon 
intracellular dialysis of NAADP and PI(3,5)P2, respectively, and the role of mTOR in these processes.  
 
RESULTS 
TPC2 deletion in pulmonary arterial myocytes abolishes global Ca2+ waves in response to NAADP but 
not PI(3,5)P2, I(1,4,5)P3 or cADPR 
We examined the action of various Ca2+ mobilising messengers in pulmonary arterial myocytes prepared 
from wild type mice and Tpcn2 knockout mice (2, 12), by employing intracellular dialysis from a patch 
pipette under voltage-clamp, with the holding potential set to -40 mV to inactivate voltage-gated Ca2+ 
channels. Intracellular dialysis of NAADP induced global Ca2+ waves in acutely isolated pulmonary arterial 
myocytes from wild type mice (Fig. 1A). By contrast NAADP did not induce a measurable Ca2+ transient in 
paired experiments on myocytes derived from Tpcn2 knockout mice (Fig. 1A), as assessed by the Fura-2 
F340 / F380 ratio. In contrast, the response to intracellular dialysis of either PI(3,5)P2, I(1,4,5)P3 or cADPR 
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was similar in myocytes derived from Tpcn2 knockout mice when compared to wild type cells (Fig. 1B, 1C, 
1D, 1E). 
Consistent with our previous studies on rat pulmonary arterial myocytes (14), the response of mouse 
myocytes to NAADP was abolished by depletion of acidic Ca2+ stores with bafilomycin-A1 (Fig. 1F) and 
attenuated following depletion of sarcoplasmic reticulum (SR) Ca2+ stores by pre-incubation with the SR 
Ca2+ ATPase inhibitor thapsigargin (Fig. 1G), suggesting that lysosomal Ca2+ bursts are subsequently 
amplified by Ca2+-induced Ca2+ release from SR stores. Nevertheless, the failure of NAADP to induce Ca2+ 
transients in myocytes from Tpcn2 knockout mice was not due to the loss of releasable, acidic Ca2+ stores, 
because pronounced Ca2+ transients were evoked upon lysis of lysosomes by glycyl-L-phenylalanine-2-
naphthylamide (GPN, (15); Fig. 1H, 1I) and upon depletion of acidic stores by application of the vacuolar 
proton pump (V-H+-ATPase) inhibitor bafilomycin-A1 (Fig. 1J, 1K, 1L, 1M). Furthermore and consistent 
with previous studies (16-19), we found that two different voltage-gated Ca2+ channel antagonists, the 
dihydropyridine nifedipine and the phenylalkylamine verapamil, blocked NAADP-induced Ca2+ signals in 
pulmonary arterial myocytes (Fig. 2A, 2B) and in HEK293 cells stably over-expressing hTPC2 (Fig. 2C) to 
comparable extents (Fig. 2D). These results are consistent with verapamil blocking the Na+ conductance 
carried by hTPC2 (9). From these data, we conclude that irrespective of the continued presence of releasable, 
acidic Ca2+ stores, TPC1, functional ryanodine receptors and I(1,4,5)P3 receptors, TPC2 is required for the 
induction of global Ca2+ signals by NAADP, but by contrast is not necessary for Ca2+ signaling by PI(3,5)P2, 
I(1,4,5)P3 or cADPR, at least in the cell types studied here. Consistent with this view, double blind paired 
analysis showed that intracellular dialysis of NAADP induced Ca2+ transients in HEK293 cells that stably 
over-expressed EGFP-tagged hTPC2 but not in those expressing its inactive mutant (N653K) that does not 
support Na+ conductance (Fig. S1A, S1B). As previously reported (9), we found by direct 
electrophysiological measurements of isolated lysosomes that hTPC2 conferred a PI(3,5)P2-gated, NAADP-
insensitive Na+ conductance. However, in the presence of high luminal and “cytoplasmic” Ca2+ (60 mM 
pipette, 200 µM bath, which reproduces previously used conditions (11)), TPC2 supported an NAADP- and 
PI(3,5)P2-sensitive Ca2+ conductance in our hands (Fig. S2A, S2B, S2C, S2E), consistent with previous 
reports on the capacity of TPC2 to support a small (7), NAADP-sensitive Ca2+ conductance (11). 
 
Rapamycin induces Ca2+ signals through acidic stores in an mTOR- and TPC2-dependent manner  
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Extracellular application of rapamycin induced concentration-dependent Ca2+ signals in hTPC2 expressing 
HEK293 cells (Fig. 3A, 3B, 3C, 3D, 3E, 3H); by contrast rapamycin induced small Ca2+ transients in wild 
type HEK293 cells, which have low TPC2 abundance (2). Rapamycin triggered Ca2+ transients in hTPC2 
expressing HEK293 cells at as low a concentration as 100 nmol/L (Fig. 3A). At the higher concentrations 
tested, rapamycin-evoked Ca2+ transients were multi-phasic, characterized by an initial large transient 
followed by Ca2+ oscillations that were variable in number and magnitude, and all were superimposed upon 
what appeared to be a slower, more uniform and prolonged Ca2+ signal (Fig. 3I). However, the concentration-
response curve for rapamycin-induced Ca2+ signals was bell-shaped, peaking at 30 µmol/L and exhibiting 
progressive levels of “desensitization” between 100 and 300 µmol/L, at which concentration 
rapamycin-induced desensitization occurred without a prior Ca2+ signal being evoked (Fig. 3H). These 
results are consistent with our previous reports on the nature of the response of these cells (20) and the 
response of pulmonary arterial myocytes (14) to NAADP. Although rapamycin inhibits mTORC1 at low 
concentrations, we found that at the high concentration that gave the peak response in the Ca2+ assay (30 
µmol/L), the drug decreased mTORC1 activity in HEK293 cells faster than at the lower concentrations (300 
nmol/L), as indicated by S6K phosphorylation (Fig. S3A, S3B). Therefore, 30 µmol/L rapamycin was used 
in all subsequent experiments to insure robust and reproducible responses. 
The response to 30 µmol/L rapamycin (Fig. 3I) was abolished by prior depletion of acidic Ca2+ stores with 
bafilomycin-A1 (Fig. 3J) and attenuated by pre-incubation of cells with thapsigargin (Fig. 3K). Thapsigargin 
blocked the fast oscillating Ca2+ transients but not the slow progressive rise in Ca2+ on which these were 
superimposed, suggesting that the Ca2+ oscillations likely result from Ca2+-induced Ca2+ release from the 
endoplasmic reticulum triggered by prior Ca2+ release from acidic Ca2+ stores. Furthermore, all signals were 
abolished by pre-incubation of cells with nifedipine (Fig. 3L). In pulmonary arterial myocytes, rapamycin 
induced Ca2+ transients that were mostly biphasic, characterized by a single rapid, global Ca2+ transient 
which was once again superimposed on an underlying, slower transient (Fig. 3M). Occasionally the initial, 
fast Ca2+ transient was, as for HEK293 cells, followed by multiple smaller transients which were all 
superimposed on the slower underlying Ca2+ signal, but for pulmonary arterial myocytes such Ca2+ 
oscillations were not a common feature of the response to rapamycin. In pulmonary arterial myocytes, 
rapamycin-evoked Ca2+ transients were blocked by prior depletion of acidic Ca2+ stores with bafilomycin-A1 
(Fig. 3N), attenuated by pre-incubation with thapsigargin (Fig. 3O) or ryanodine (Fig. 3O), and abolished by 
pre-incubation with nifedipine (Fig. 3P). These results were similar to those obtained in HEK293 cells stably 
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over-expressing hTPC2 and to that previously reported for NAADP-evoked Ca2+ signals in pulmonary 
arterial myocytes (14). Due to the more complex nature of rapamycin-induced Ca2+ signals, from this point 
forward we analyzed the responses for mTOR inhibition by measuring the “area under the curve” (AUC) 
which may provide a more accurate assessment of outcomes (Fig. 4A, 4B). Consistent with previous findings 
of others for TPC2 (19), rapamycin- and NAADP-induced Ca2+ transients were also blocked by tetrandrine 
(Fig. 4C, 4D), which has previously been shown to activate autophagy (21) and block TPC2 (22). Moreover, 
similar to rapamycin, the mTOR inhibitor torin-2 also evoked biphasic Ca2+ transients in HEK293 cells 
stably over-expressing hTPC2 and in pulmonary arterial myocytes (Fig. 4C, 4D). These Ca2+ transients 
exhibited characteristics similar to those induced by NAADP (Fig. S4A, S4B, S4C, S4D). Increases in 
cytoplasmic Ca2+ concentration were also induced by torin-1, but these were sustained and did not return to 
baseline during the course of these experiments (Fig. S5A, S5B, S5C).  
Neither rapamycin nor torin-2 induced measurable Ca2+ transients in myocytes derived from Tpcn2 knockout 
mice (Fig. 5A, 5B, 5C). Moreover, shRNA knockdown of mTOR in HEK293 cells that stably overexpressed 
hTPC2 attenuated Ca2+ transients induced by rapamycin and NAADP (Fig. 5D, 5G). These data suggest that 
rapamycin induces Ca2+ transients in a TPC2-dependent manner by inhibiting mTOR, and TPC2 may 
therefore be the point of convergence for the induction of Ca2+ signals by NAADP and mTOR inhibition. 
This notion was confirmed by cross-desensitization of signaling between mTOR inhibition and NAADP. 
NAADP-induced Ca2+ signals were abolished by pre-incubation with rapamycin or torin-2 in both 
pulmonary arterial smooth muscle cells (Fig. 6A, 6B, 6C, 6D) and in HEK293 cells that stably over-
expressed hTPC2 (Fig. 6E, 6H). However, the effects of prior intracellular dialysis of high, desensitizing 
concentrations of NAADP on rapamycin-induced Ca2+ signals were more variable, but generally appeared to 
have little effect. In rat pulmonary arterial myocytes, following intracellular dialysis of NAADP, Ca2+ 
transients evoked by rapamycin were marginally attenuated only when assessed by AUC and these 
differences were not significant (Fig. 6C, 6D). Moreover, in hTPC2-HEK293 cells, prior intracellular 
dialysis of desensitizing concentrations of NAADP did not affect Ca2+ transients (Fig. 6G, 6H). This contrary 
outcome may be due to disparities with respect to the amount of time in which pulmonary arterial myocytes 
and hTPC2 expressing HEK293 cells could be held in the whole-cell configuration and the time-dependence 
of the process of desensitization by high concentrations of NAADP. Alternatively, NAADP may self-
desensitize this macromolecular signaling complex at a point upstream of mTOR.  
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Rapamycin evokes bafilomycin-A1- and nifedipine-sensitive Ca2+ signals proximal to TPC2 in 
HEK293 cells 
We next used HEK293 cells that stably over-expressed GCaMP5-hTPC2, in which the genetically encoded 
Ca2+ indicator GCaMP5 was fused to the cytoplasmic N-terminus of TPC2, allowing detection of Ca2+ 
signals arising near the lysosome-localized TPC2. Confocal imaging showed that GCaMP5-hTPC2 
specifically labeled Lysotracker-red positive vesicles, which formed either static clusters of variable density 
or smaller motile units (Fig. 7A). Application of rapamycin induced slowly developing increases in 
fluorescence that arose and returned to baseline with a time course of 60-120s (Fig. 7B). These followed a 
similar time course to the slower, thapsigargin-insensitive signals recorded by way of Fura-2 fluorescence 
ratio (Fig. 3K). These findings suggest that the sampling interval (0.2 Hz) for confocal experiments did not 
provide the temporal resolution necessary to reveal those fast Ca2+ transients superimposed on the slower, 
thapsigargin-insensitive components of rapamycin-induced signals described above. Consistent with this 
view, these signals were blocked by prior depletion of acidic stores by bafilomycin-A1 and by pre-incubation 
with nifedipine, but were not affected by pre-incubation of cells with thapsigargin (Fig. 7C, 7D, 7E). 
Furthermore, nifedipine reduced basal fluctuations in GCaMP5-hTPC2 fluorescence relative to control, 
providing indirect support for the view that this L-type voltage-gated Ca2+ channel antagonist directly 
inhibits lysosomal Ca2+ efflux, whether through TPC2 or a distinct pathway governed by activation of TPC2. 
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DISCUSSION 
Using fully differentiated, acutely isolated pulmonary arterial myocytes to examine the role of TPC2 in 
lysosomal Ca2+ signaling (23-25) in combination with HEK293 cell lines stably over-expressing human 
TPC2, we showed that TPC2 was required for global Ca2+ transients in response to intracellular dialysis of 
NAADP. Briefly, NAADP failed to induce global Ca2+ transients in pulmonary arterial myocytes from Tpcn2 
knockout mice although both lysosomes and the SR retained replete and releasable Ca2+ stores, mobilisation 
of the former being triggered by GPN and bafilomycin-A1, and the latter by intracellular dialysis of 
I(1,4,5)P3 and cADPR. TPC1 (2), ryanodine receptors and I(1,4,5)P3 receptors remain available in 
pulmonary arterial myocytes (14, 20, 24-26) from Tpcn2 knockout mice, thereby demonstrating that TPC2 is 
required for the induction of global Ca2+ waves by NAADP in this cell type (24, 25). 
These findings recapitulate our previous observations on HEK293 cells, which suggested that over-
expression of hTPC2 is required to support NAADP-dependent global Ca2+ signals (2, 20), and that 
recombinant expression of ryanodine receptors is required for cADPR-induced Ca2+ transients (20). These 
findings are consistent with the observation that HEK293 cells primarily rely on I(1,4,5)P3 receptors to 
mediate global Ca2+ signals, while exhibiting little or no endogenous functional expression of either TPCs (2) 
or ryanodine receptors (27). On the other hand, these findings argue against the proposal that PI(3,5)P2-gated 
Ca2+ signals arise in a TPC2-dependent manner in these cells, regardless of whether TPC2 itself supports a 
Na+-specific conductance (9) or both Ca2+ and Na+ conductances (11). This view was strengthened by our 
studies on HEK293 cells and pulmonary arterial myocytes, in which we found that PI(3,5)P2 not only evoked 
Ca2+ oscillations in HEK293 cells stably overexpressing hTPC2 and pulmonary arterial myocytes derived 
from wild type mice, but that PI(3,5)P2 also did so in pulmonary arterial myocytes from Tpcn2 null mice and 
in wild type HEK293 cells, in which endogenous expression of TPC2 is too low to support NAADP-
dependent global Ca2+ signals (2, 20). These outcomes are therefore consistent with the retention of 
PI(3,5)P2-gated cation currents in cells from Tpcn1 and Tpcn2 double knockout mice (11). Accordingly, 
others have shown that PI(3,5)P2 can gate various channel families other than TPCs, including TRPML1 and 
ryanodine receptors (28-30). We cannot, however, rule out the possibility that PI(3,5)P2 availability is 
required to support TPC2 activity. 
We found that rapamycin and another mTOR inhibitor torin-2 also induced Ca2+ signals by mobilizing 
bafilomycin-A1-sensitive, acidic stores in a manner that was markedly attenuated by shRNA knockdown of 
 
9 
 
mTOR and abolished by Tpcn2 deletion. These data suggest that mTOR inhibitors induce Ca2+ release from 
lysosomes through TPC2 in an mTOR-dependent manner rather than by directly binding to TPC2, although 
we cannot rule out the possibility that some mTOR inhibitors may also directly activate TPC2; torin-1 
appeared to have a distinct mode of activating TPC2 (Fig. S5A, S5B, S5C, S5D). Moreover, using HEK293 
cells stably over-expressing GCaMP5-hTPC2 we showed that rapamycin increased lysosomal Ca2+ flux 
proximal to hTPC2 itself. This finding is not inconsistent with the findings of others which suggest that 
mTOR is an endogenous inhibitor of PI(3,5)P2-gated Na+ currents carried by TPC2 (10). Although small 
when compared to their estimated Na+ permeability, it appears that endogenous TPC2 may support a Ca2+ 
conductance sufficient to trigger global Ca2+ signals due to amplification of lysosomal Ca2+ bursts at 
lysosome-sarcoplasmic reticulum nanojunctions (23-25), as has been suggested by computer simulations 
(23) and electrophysiological investigations on the ion selectivity conferred by the filter sequence of the 
human TPC2 channel pore (7) and whole-endolysosomal recordings for human TPC2 carried out with Ca2+ 
as the major permeant ion by others (7)) and us (Fig. S2A, S2B, S2C, S2D). This notion is supported by our 
demonstration of cross-desensitisation between mTOR inhibitor and NAADP with respect to their capacity 
to evoke Ca2+ signals in both pulmonary arterial myocytes and in HEK293 cells stably over-expressing 
hTPC2. This observation is consistent with the indirect activation of TPC2 by NAADP through associated 
proteins (31, 32) and may confirm the primary physiological role of TPC2, in that mTOR-dependent Ca2+ 
mobilization may modulate the luminal pH of lysosomes (33, 34) and thus autophagic flux (12, 35).  
We conclude that inactivation of mTOR is a major endogenous pathway for initiating lysosomal Ca2+ release 
in HEK293 cells stably overexpressing hTPC2 and in pulmonary arterial myocytes. Thus, the mTORC1-
TPC2 complex may act as the endogenous gatekeeper of lysosomal Ca2+ flux, which may in turn impact 
autophagy termination and mTOR reactivation (12). Because mTORC1-dependent myocyte proliferation 
promotes the progression of pulmonary hypertension (13), for which current therapies are ineffective, TPC2 
may be a potential therapeutic target in idiopathic pulmonary hypertension and pulmonary hypertension 
secondary to lysosomal dysfunction associated with Pompe and Gaucher diseases (36, 37). In this respect, 
our demonstration that nifedipine attenuates basal, NAADP- and rapamycin-evoked lysosomal Ca2+ release 
in a TPC2-dependent manner is notable, because this Ca2+ channel antagonist is used in the treatment of 
pulmonary hypertension (38, 39). 
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MATERIALS AND METHODS 
Preparation of pulmonary arterial smooth muscle cells and HEK293 cell lines stably expressing 
human TPC2.  
Experiments were performed in accordance with the United Kingdom Animals (Scientific Procedures) Act 
1986.  
Single arterial smooth muscle cells were isolated from second order branches (external diameter ~1mm) of 
the pulmonary artery. Briefly, the arteries were dissected from lungs of male wild type (C57/Bl6) and Tpcn2 
knockout(2) mice (28-33g), or Wistar rats (250-300g), and single cells acutely isolated from pulmonary 
arterial smooth muscle from mouse or rat as previously described(24), and placed in low Ca2+ solution of the 
following composition (in mmol / L): 135 NaCl, 5 KCl, 1 MgCl2, 0.5 NaH2PO4, 0.5 KH2PO, 15 NaHCO3, 
0.16 CaCl2, 0.5 EDTA, 10 glucose, 10 taurine, and 10 Hepes, pH 7.4. For cell isolation, dissected arteries 
were transferred into fresh low Ca2+ solution containing  (in mg / ml) 1 papain, 0.8 dithiothreitol and 0.7 
bovine serum albumin and incubated for 10 min at 37ºC and gently triturated using a fire polished glass 
pipette in order to obtain dispersed pulmonary arterial smooth muscle cells (PASMCs). Acutely isolated 
PASMCs were then plated in a 35-mm cell-culture dish (Fluorodish - World Precision Instruments Inc.) and 
used within 24 hrs. The HEK293 cell line stably expressing human TPC2 was also developed and cultured as 
previously described (2). Site-directed mutagenesis was performed to generate a TPC2 N653K mutant that 
lacked a Na+ conductance, using the QuikChange Site-Directed Mutagenesis Kit (Stratagene). The mutation 
was confirmed by DNA sequencing. 
Ca2+ imaging  
Cells were incubated for 30 min with 5 µM Fura-2-AM in nominally Ca2+ free physiological salt solution 
(PSS) of the following composition (in mmol / L): 130 NaCl, 5.2 KCl, 1 MgCl2, 10 glucose, 10 Hepes, pH 
7.45, in an experimental chamber that was then placed on a Leica DMIRBE inverted microscope after 
washing with Ca2+ containing (1.7 mmol / L CaCl2), Fura-2 free PSS for at least 30 min prior to 
experimentation. PSS was of the following composition (mmol / L): 130 NaCl, 5.2 KCl, 1 MgCl2, 1.7 CaCl2, 
10 glucose, 10 Hepes, pH 7.45. Cytoplasmic Ca2+ concentration was reported by Fura-2 fluorescence ratio 
(F340 / F380 excitation; emission 510 nm). Emitted fluorescence was recorded at 22 °C with a sampling 
frequency of 0.5 Hz, using a Hamamatsu 4880 CCD camera and a Zeiss Fluar 40x, 1.3 n.a. oil immersion 
objective. Background subtraction was performed on-line. Analysis was completed using Openlab imaging 
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software (Perkin-Elmer, UK). NAADP (10 nmol / L) was applied intracellularly into single cells in the 
whole-cell configuration of the patch-clamp technique (voltage-clamp mode; holding potential = -40 mV). 
The pipette solution contained (in mmol / L): 140 KCl, 10 Hepes, 1 MgCl2 and 5 µmol / L Fura-2 (free acid), 
pH 7.4, nominally Ca2+ free (~100 nmol / L). The seal resistance was ≥3 GΩ throughout each experiment. 
Series and pipette resistance was ≤10 MΩ and ≤3 MΩ, respectively, as measured by an Axopatch 200B 
amplifier (Axon Instruments). 
Confocal microscopy 
The GCaMP5 fluorescence ratio (expressed as F/F0; F0 = GCaMP5 fluorescence intensity at 0s; Fx = 
fluorescence intensity at time x for given region of interest) was recorded at 22 °C with a sampling frequency 
of 0.5 Hz, using A Nikon A1R+ confocal system and a Nikon Eclipse Ti inverted microscope with a Nikon 
Apo 40x λS DIC N2, 1.25 n.a. water immersion objective (Nikon Instruments Europe BV, Netherlands). 
Experiments were processed with ImageJ software (Rasband WS. ImageJ, U.S. National Institutes of Health, 
Bethesda, Maryland, USA, imagej.nih.gov/ij/, 1997—2012).  
Analysis of mTOR activities in response to rapamycin treatment by immunoblotting 
HEK293 cells were seeded in 6-well plates at 40~50% confluence and cultured overnight to reach ~70% 
confluence. Rapamycin was diluted to final concentrations of 0.3 µM and 30 µM in complete culture 
medium (DMEM supplemented with 10% fetal bovine serum) and warmed to 37°C before being added to 
the cells. At desired times (1-60 min) after the addition of rapamycin, the medium was aspirated and 200 µl 
of 1X SDS sampling buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 1% β-mercaptoethanol, 12.5 mM 
EDTA and 0.02% bromophenol blue, pH 6.8) were immediately added to cause cell lysis. Cell lysates were 
then collected into 1.5 ml Eppendorf tubes and sonicated for 15 seconds before boiling at 99°C for 5 min. 
Lysates were resolved in 7.5% Tris-Glycine SDS-PAGE gel and analyzed using mouse-anti-phospho-S6K 
(Thr389) (1:1000, Cell Signaling Technology Cat # 9206) and rabbit-anti-S6K (1:1000, Cell Signaling 
Technology Cat # 9202) primary antibodies. Dylight 800 goat-anti-mouse (1:5000, Invitrogen Cat # SA5-
10176) and Dylight 680 goat-anti-rabbit (1:5000, Invitrogen Cat # 21109) secondary antibodies were used to 
reveal signals and blots were scanned with fluorescent immunoblot instruments and software by LI-COR 
Odyssey Software Images. 
Whole-endolysosome patch clamp experiments 
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Endolysosomal patch clamp recordings were performed in isolated enlarged endolysosomes using a modified 
patch-clamp method (9,11,40). HEK293 cells stably expressing TPC2-EGFP were treated with 1 µM 
vacuolin-1 for 12-36 hrs. Electrophysiological recordings were performed using an EPC10 USB acquisition 
system (HEKA). Patchmaster software (HEKA) was used to record and analyze data. Recording solutions 
followed either that by Ruas et al. (11) or that by Wang et al. (9), which differ mainly in that the pipette 
solution was either Ca2+-rich (Na+-free) or Na+-rich, respectively. The Ca2+-rich pipette solution contained 
(in mM) 70 K-methanesulfonate (MSA), 60 Ca-MSA, 1 MgCl2, 10 HEPES (pH adjusted with MSA to 4.6 
and mannitol used to adjust osmolarity); the bath solution contained (in mM) 130 K-MSA, 0.2 mM Ca-
MSA, 10 HEPES (pH adjusted with KOH to 7.2). The Na+-rich pipette solution had (in mM) 145 NaCl, 5 
KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, 10 MES, 10 glucose (pH adjusted with NaOH to 4.6); the bath solution 
contained (in mM) 140 K-gluconate, 4 NaCl, 1 EGTA, 2 MgCl2, 0.39 CaCl2, 20 HEPES (pH adjusted with 
KOH to 7.2; free [Ca2+] = 100 nM). In brief, an isolated pipette was used to slice the cell membrane and 
release endolysosomes labeled with EGFP fluorescence. Only one enlarged endolysosome vacuole was 
recorded from each coverslip. Then a freshly polished recording pipette was used to form a gigaseal to the 
vacuole. ZAP pulses (fast pulses of -400 mV to -1,000 mV in 50 ms to 100 ms durations) were used to 
establish the whole-endolysosome configuration. Capacitance transients were compensated automatically. 
The holding potential was set at 70 mV and inside out recording mode was used for data acquisition, in 
which the inward currents were defined as currents flowing out of lysosomal lumen into the cytosol. Voltage 
ramps from -150 mV to +150 mV within 200 ms were applied every second. A 20 ms step to -150 mV and a 
20 ms step to +150 mV were included at the beginning and end, respectively, of each ramp. Currents at -150 
mV were used for further analysis.  
Data presentation and statistical analysis  
Data are presented as the mean ± SEM for n experiments. Comparisons between groups were by Kruskal 
Wallis test with Dunn’s multiple comparison test, and non-parametric unpaired t-test. Probability values less 
than 0.05 were considered to be statistically significant. 
Drugs and chemicals  
Unless otherwise stated all compounds were from Sigma-Aldrich. 
SUPPLEMENTARY MATERIALS 
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Fig. S1. Blind experiments on active and null hTPC2 constructs demonstrate robustness of intracellular 
dialysis technique. 
Fig. S2. Na+ and Ca2+ currents mediated by endolysosomal TPC2 in response to NAADP and PI(3,5)P2. 
Fig. S3. High and low concentrations of rapamycin suppress mTORC1 activities in HEK 293 cells at 
different rates. 
Fig. S4. Torin-2 induces increases in intracellular Ca2+ in HEK 293 cells stably overexpressing hTPC2 and in 
rat pulmonary arterial myocytes. 
Fig. S5. Torin-1 induces low-magnitude, sustained increases in intracellular Ca2+ in HEK 293 cells stably 
overexpressing hTPC2 and in rat pulmonary arterial myocytes. 
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Fig. 1. Deletion of TPC2 in pulmonary arterial myocytes blocks Ca2+ transients evoked by NAADP but 
not those triggered by PI(3,5)P2, I(1,4,5)P3 or cADPR A, Upper panels show a bright field image of an 
acutely isolated mouse pulmonary arterial myocyte (PASMC), and a series of pseudo-colour images of the 
Fura-2 fluorescence ratio (F340/F380) recorded in the same cell during intracellular dialysis from a patch 
pipette of 10 nmol/L NAADP. Lower panel, corresponding record (black) of F340/F380 ratio against time; 
the time points at which pseudo-colour images were acquired are indicated by the numbered lines. WC 
indicates the beginning of intracellular dialysis upon entering the whole-cell configuration. The red, blue, 
cyan and green records show the effect of NAADP in myocytes from Tpcn2 knockout mice. B-D, As in A 
but showing responses of myocytes from Tpcn2 knockout mice to intracellular dialysis of PI(3,5)P2 (B), 
I(1,4,5)P3 (C) or cADPR (D). E, Bar chart shows the mean ± SEM for each stimulus across all cells studied 
(number of cells (n) indicated above bars). ns, not significant; **P < 0.01; ***P  <  0.001; ****P  <  0.0001. F, 
Upper panel shows a bright field image of a PASMC acutely isolated from a wild type (WT) mouse, and a 
series of pseudo-colour images of the Fura-2 fluorescence ratio (F340 / F380) recorded in the same cell 
during intracellular dialysis from a patch pipette of 10 nmol / L NAADP. Lower panel, corresponding record 
(black) of F340 / F380 ratio against time; the time points at which pseudo-colour images were acquired are 
indicated by the numbered lines. WC indicates the beginning of intracellular dialysis upon entering the 
whole-cell configuration. Red record shows the effect of NAADP after pre-incubation (≥50 min) of a 
myocyte with 1 µmol / L bafilomycin-A1 (Baf-A1). G, as in F but with a blue record that shows the effect of 
NAADP in a different cell after pre-incubation with the SR Ca2+ ATPase inhibitor thapsigargin (1 µmol / L; 
≥ 40 minutes). H, Shows the response of a WT mouse PASMC to extracellular application of 25 µmol / L 
GPN. I, as in H but showing the response of a myocyte from a Tpcn2 knockout (KO) mouse. J and K, as in H 
and I but showing responses to 1 µmol / L bafilomycin-A1. L and M, Bar charts show the mean ± SEM 
(number of cells (n) indicated above bars) for the experiments shown in F, G, H and J for wild type (L) and I 
and K for Tpcn2 KO mice (M). *P  <  0.05. 
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Fig. 2 Nifedipine and verapamil block NAADP-evoked Ca2+ transients A, Upper panels show a bright 
field image of an acutely isolated rat pulmonary arterial myocyte (PASMC), and a series of pseudo-colour 
images of the Fura-2 fluorescence ratio (F340 / F380) recorded in the same cell during intracellular dialysis 
from a patch pipette of 10 nmol / L NAADP. Lower panel, corresponding record (black) of F340 / F380 ratio 
against time; the time points at which pseudo-colour images were acquired are indicated by the numbered 
lines. WC indicates the beginning of intracellular dialysis upon entering the whole-cell configuration. The 
magenta and brown records show the effect of NAADP in myocytes pre-incubated with 10 µmol / L 
nifedipine and 10 µmol / L verapamil, respectively. B, as in A but for an acutely isolated wild type (WT) 
mouse PASMC. C, as in A but for a HEK293 cell stably over-expressing hTPC2. D, Bar chart shows the 
mean ± SEM for each stimulus across all cells studied (number of cells (n) indicated above bars). *P  <  0.05, 
**P  <  0.01, ***P  <  0.001.  
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Fig. 3 Rapamycin induces Ca2+ transients in pulmonary arterial myocytes and hTPC2 expressing 
HEK293 cells that are blocked by bafilomycin A1 and nifedipine A to H, Example records (black) 
showing the concentration-response relationship as changes in Fura-2 fluorescence ratio (F340 / F380) 
against time during extracellular application of indicated concentrations of rapamycin (0.1-300 µmol / L) 
onto different HEK293 cells that stably expressed human TPC2. I, Upper panel shows a bright field image of 
a HEK293 cell stably over-expressing hTPC2, and a series of pseudo-colour images of F340/F380 recorded 
in the same cell during extracellular application of 30 µmol / L rapamycin. Lower panel, corresponding 
record (black) of F340 / F380 ratio against time; the time points at which pseudo-colour images were 
acquired are indicated by the numbered lines. Green record shows the effect of DMSO (vehicle control) in a 
different cell, and cyan record shows the effect of rapamycin on a wild type HEK293 cell. J, as in I but with 
a red record showing the effect of rapamycin after pre-incubation (≥50 min) of an hTPC2 expressing 
HEK293 cell with 1 µmol / L bafilomycin A1. K, as in I but with an orange record showing the effect of 
rapamycin after pre-incubation (≥50 min) of a cell with 1 µmol / L thapsigargin. L, as in I but with a 
magenta record showing the effect of rapamycin after pre-incubation (≥50 min) of a cell with 10 µmol / L 
nifedipine.  M to P, as in I to L but for acutely isolated rat pulmonary arterial myocytes, except that O shows 
an additional record in gold of the effect of rapamycin after pre-incubation (≥50 min) of a myocyte with 10 
µmol/L ryanodine.  
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Fig. 4. Comparison of the effects of rapamycin and torin-2 in pulmonary arterial smooth muscle cells 
acutely isolated from rats or mice, wild type HEK293 cells and HEK293 cells stably over-expressing 
hTPC2. A, Bar chart showing the concentration-response relationship (mean ± SEM) for the peak change in 
Fura-2 fluorescence ratio (Delta F340 / F380) during extracellular application of rapamycin onto HEK293 
cells that stably expressed hTPC2. B, as in A but for area under the curve. C, Bar chart compares the mean ± 
SEM for the peak change in Fura-2 fluorescence ratio during extracellular application of rapamycin onto 
wild type HEK293 cells, HEK293 cells that stably expressed hTPC2 and pulmonary arterial myocytes under 
all conditions studied (see key). D, as in C but for area under the curve (number of cells (n) indicated above 
bars). *P  <  0.05, **P  <  0.01, ***P  <  0.001, ****P  <  0.0001. 
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Fig. 5 Ca2+ transients induced by mTOR inhibitors in pulmonary arterial myocytes are blocked by 
deletion of TPC2 and by shRNA knockdown of mTOR. A, Upper panel shows a bright field image of a 
wild type (WT) mouse PASMC, and a series of pseudo-colour images of the Fura-2 fluorescence ratio (F340 
/ F380) recorded in the same cell during extracellular application of 30 µmol / L rapamycin. Lower panel, 
corresponding record (black) of F340/F380 ratio against time; the time points at which pseudo-colour images 
were acquired are indicated by the numbered lines. Pink record shows the response to 30 µmol / L rapamycin 
of a myocyte isolated from a Tpcn2 knockout (Tpcn2 KO) mouse. B and C, bar charts show the mean ± SEM 
(number of cells (n) indicated above bars) for the peak change in F340 / F380 during the 1st transient 
recorded (B) and the area under the curve during the response of each cell to rapamycin and torin-2 (C). 
***P  <  0.001; ****P  <  0.0001. D, Upper panel shows a bright field image of a HEK293 cell overexpressing 
hTPC2 48 hrs following transfection of scrambled shRNA, and a series of pseudo-colour images of the Fura-
2 fluorescence ratio (F340/F380) recorded in the same cell during extracellular application of 30 µmol / L 
rapamycin. Lower panel, corresponding record (black) of F340 / F380 ratio against time; the time points at 
which pseudo-colour images were acquired are indicated by the numbered lines. Green and pink records 
showthe response to DMSO and 30 µmol / L rapamycin, respectively, of two different hTPC2 expressing 
HEK293 cells that were transfected with shRNA against mTOR. E, as in D but for different cells during 
intracellular dialysis with 10 nmol / L NAADP, as performed in Fig. 1; red record for a cell 48 hrs following 
transfection of scrambled shRNA and blue record for a cell transfected with shRNA against mTOR. F and G, 
bar chart shows the mean ± SEM (number of cells (n) indicated above bars) for the experiments shown in D 
and E, for the peak change in F340 / F380 ratio induced by NAADP and the peak change attained during the 
1st transient recorded after rapamycin (C), and the area under the curve during the response to rapamycin (D). 
*P  <  0.05, ***P  <  0.001, ****P  <  0.0001.  
 
  
 
21 
 
 
 
 
 
Fig. 6 Ca2+ transients evoked by mTOR inhibition and NAADP exhibit cross-desensitisation in 
pulmonary arterial myocytes and hTPC2 expressing HEK293 cells. A, Upper panel shows a bright field 
image of a rat PASMC, and a series of pseudo-colour images of the Fura-2 fluorescence ratio (F340 / F380) 
recorded in the same cell during intracellular dialysis of 10 nmol / L NAADP. Lower panel, corresponding 
record (black) of F340/F380 ratio against time; the time points at which pseudo-colour images were acquired 
are indicated by the numbered lines. WC indicates the beginning of intracellular dialysis upon entering the 
whole-cell configuration. Blue and brown records show, respectively, the response to 10 nmol/L NAADP of 
myocytes pre-incubated (30 min) with 30 µmol / L rapamycin or 300 nmol / L torin-2. B, as in A but for 
rapamycin in the absence of (red) and 2 min after intracellular dialysis of 100 µmol / L NAADP (pink). C 
and D, bar charts show the mean ± SEM for the experiments shown in A and B, for the peak change induced 
by 10 nmol / L NAADP and the peak change attained during the 1st transient recorded after 30 µmol / L 
rapamycin (C), and the area under the curve during the response to rapamycin (D). E-H, as in A-D but for 
HEK293 cells stably overexpressing hTPC2. Number of cells (n) indicated above bars. *P  <  0.05, 
**P  <  0.01, ***P  <  0.001,****P  <  0.0001. 
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Fig. 7. Rapamycin induces bafilomycin and nifedipine-sensitive Ca2+ signals proximal to lysosomes in 
HEK293 cells that stably over-express GCaMP5-TPC2. A, Deconvolved confocal images show a 3D 
reconstruction, from left to right, of a single HEK293 cell stably expressing GCaMP5-hTPC2 (green), the 
distribution of Lysotracker-red (red) labeling within the same cell and a merged image depicting regions of 
colocalisation (yellow). B, Upper panels show confocal images of a HEK293 cell overexpressing GCaMP5-
hTPC2 (Green) during extracellular application of 30 µmol / L rapamycin. Lower panel, corresponding 
record (black) of F/F0 ratio against time; the time points at which confocal images were acquired are 
indicated by the numbered lines. Green record shows the effect of DMSO (vehicle control) in a different cell. 
C, as in B but showing the response of different cells to 30 µmol / L rapamycin after pre-incubation with 1 
µmol / L thapsigargin (black), 1 µmol / L bafilomycin A1 (red) and 10 µmol / L nifedipine (pink). D and E, 
Bar charts show the mean ± SEM for the peak change in F/F0 (D) and the area under the curve during the 
response to rapamycin (E). Number of cells (n) indicated above bars. *P  <  0.05, **P  <  0.01. 
 
 
 
 
